RBM39 and cancer: Previous studies have reported that immunomodulatory drugs, such as sulfonamides, can recruit the splicing factor RBM39 to the E3 ligase substrate receptor DCAF15, leading to ubiquitination and degradation of RBM39, which resulted in altered RNA splicing and death in some cancer cell lines.40, 41, 42, 43